An Observational Study on Treatment Compliance by Children Treated With Growth Hormone

Novo Nordisk A/S

Overview

This study is conducted in Europe. This observational study aims at evaluating compliance with growth hormone treatment in children and identifying factors influencing compliance.

Study Type

OBSERVATIONAL

Conditions

Growth Hormone Disorder Growth Hormone Deficiency in Children

Interventions

No treatment givenBEHAVIORAL

No treatment given to study participants, only behaviorial patterns with respect to treatment compliance is observed.

Eligibility

Sex: ALLMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Child treated for at least one year with growth hormone any growth hormone product * Followed by the participating paediatrician for at least 1 year. Exclusion Criteria: * Refusal to participate * Child and/or parent unable to give consent or fill out the questionnaires * Child participating in a therapeutic trial

Outcomes

Primary Outcomes

Average number of injections omitted during the previous month

Time frame: measured over the past 2 months (retrospective data collection)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.